Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135242378> ?p ?o ?g. }
- W2135242378 abstract "Children with congenital heart disease often undergo heart surgery at a young age. They are at risk for postoperative low cardiac output syndrome (LCOS) or death. Milrinone may be used to provide inotropic and vasodilatory support during the immediate postoperative period.This review examines the effectiveness of prophylactic postoperative use of milrinone to prevent LCOS or death in children having undergone surgery for congenital heart disease.Electronic and manual literature searches were performed to identify randomised controlled trials. We searched CENTRAL, MEDLINE, EMBASE and Web of Science in February 2014 and conducted a top-up search in September 2014 as well as clinical trial registries and reference lists of published studies. We did not apply any language restrictions.Only randomised controlled trials were selected for analysis. We considered studies with newborn infants, infants, toddlers, and children up to 12 years of age.Two review authors independently extracted data according to a pre-defined protocol. We obtained additional information from all study authors.Three of the five included studies compared milrinone versus levosimendan, one study compared milrinone with placebo, and one compared milrinone verus dobutamine, with 101, 242, and 50 participants, respectively. Three trials were at low risk of bias while two were at higher risk of bias. The number and definitions of outcomes were non-uniform as well. In one study comparing two doses of milrinone and placebo, there was some evidence in an overall comparison of milrinone versus placebo that milrinone lowered risk for LCOS (risk ratio (RR) 0.52, 95% confidence interval (CI) 0.28 to 0.96; 227 participants). The results from two small studies do not provide enough information to determine whether milrinone increases the risk of LCOS when compared to levosimendan (RR 1.22, 95% CI 0.32 to 4.65; 59 participants). Mortality rates in the studies were low, and there was insufficient evidence to draw conclusions on the effect of milrinone compared to placebo or levosimendan or dobutamine regarding mortality, the duration of intensive care stay, hospital stay, mechanical ventilation, or maximum inotrope score (where available). Numbers of patients requiring mechanical cardiac support were also low and did not allow a comparison between studies, and none of the participants of any study received a heart transplantation up to the end of the respective follow-up period. Time to death within three months was not reported in any of the included studies. A number of adverse events was examined, but differences between the treatment groups could not be proven for hypotension, intraventricular haemorrhage, hypokalaemia, bronchospasm, elevated serum levels of liver enzymes, or a reduced left ventricular ejection fraction < 50% or reduced left ventricular fraction of shortening < 28%. Our analysis did not prove an increased risk of arrhythmias in patients treated prophylactically with milrinone compared with placebo (RR 3.59, 95% CI 0.83 to 15.42; 238 participants), a decreased risk of pleural effusions (RR 1.78, 95% CI 0.92 to 3.42; 231 participants), or a difference in risk of thrombocytopenia on milrinone compared with placebo (RR 0.86, 95% CI 0.39 to 1.88; 238 participants). Comparisons of milrinone with levosimendan or with dobutamine, respectively, did not clarify the risk of arrhythmia and were not possible for pleural effusions or thrombocytopenia.There is insufficient evidence of the effectiveness of prophylactic milrinone in preventing death or low cardiac output syndrome in children undergoing surgery for congenital heart disease, compared to placebo. So far, no differences have been shown between milrinone and other inodilators, such as levosimendan or dobutamine, in the immediate postoperative period, in reducing the risk of LCOS or death. The existing data on the prophylactic use of milrinone has to be viewed cautiously due to the small number of small trials and their risk of bias." @default.
- W2135242378 created "2016-06-24" @default.
- W2135242378 creator A5019261801 @default.
- W2135242378 creator A5023586883 @default.
- W2135242378 creator A5035948406 @default.
- W2135242378 date "2015-03-25" @default.
- W2135242378 modified "2023-10-14" @default.
- W2135242378 title "Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease" @default.
- W2135242378 cites W1492937880 @default.
- W2135242378 cites W1574696482 @default.
- W2135242378 cites W1579742331 @default.
- W2135242378 cites W1963546783 @default.
- W2135242378 cites W1965315167 @default.
- W2135242378 cites W1978236674 @default.
- W2135242378 cites W2004481100 @default.
- W2135242378 cites W2010184383 @default.
- W2135242378 cites W2013524192 @default.
- W2135242378 cites W2015510321 @default.
- W2135242378 cites W2016475679 @default.
- W2135242378 cites W2031541956 @default.
- W2135242378 cites W2034185700 @default.
- W2135242378 cites W2035600329 @default.
- W2135242378 cites W2036250278 @default.
- W2135242378 cites W2039246192 @default.
- W2135242378 cites W2039418122 @default.
- W2135242378 cites W2040395293 @default.
- W2135242378 cites W2048173762 @default.
- W2135242378 cites W2061463574 @default.
- W2135242378 cites W2063844574 @default.
- W2135242378 cites W2065775430 @default.
- W2135242378 cites W2072841444 @default.
- W2135242378 cites W2073090015 @default.
- W2135242378 cites W2074878994 @default.
- W2135242378 cites W2085028768 @default.
- W2135242378 cites W2088095316 @default.
- W2135242378 cites W2090085923 @default.
- W2135242378 cites W2091807793 @default.
- W2135242378 cites W2093808807 @default.
- W2135242378 cites W2096610687 @default.
- W2135242378 cites W2098055101 @default.
- W2135242378 cites W2103851340 @default.
- W2135242378 cites W2112789217 @default.
- W2135242378 cites W2117277603 @default.
- W2135242378 cites W2126930838 @default.
- W2135242378 cites W2127651839 @default.
- W2135242378 cites W2141900287 @default.
- W2135242378 cites W2143350455 @default.
- W2135242378 cites W2144397934 @default.
- W2135242378 cites W2150050635 @default.
- W2135242378 cites W2156098321 @default.
- W2135242378 cites W2163181497 @default.
- W2135242378 cites W2163755347 @default.
- W2135242378 cites W2164844592 @default.
- W2135242378 cites W2164902492 @default.
- W2135242378 cites W2165522294 @default.
- W2135242378 cites W2169629898 @default.
- W2135242378 cites W2170952317 @default.
- W2135242378 cites W2171719439 @default.
- W2135242378 cites W2172221324 @default.
- W2135242378 cites W2325219355 @default.
- W2135242378 cites W2328103083 @default.
- W2135242378 cites W2991792334 @default.
- W2135242378 cites W4235315107 @default.
- W2135242378 cites W4244562396 @default.
- W2135242378 doi "https://doi.org/10.1002/14651858.cd009515.pub2" @default.
- W2135242378 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25806562" @default.
- W2135242378 hasPublicationYear "2015" @default.
- W2135242378 type Work @default.
- W2135242378 sameAs 2135242378 @default.
- W2135242378 citedByCount "33" @default.
- W2135242378 countsByYear W21352423782015 @default.
- W2135242378 countsByYear W21352423782016 @default.
- W2135242378 countsByYear W21352423782017 @default.
- W2135242378 countsByYear W21352423782018 @default.
- W2135242378 countsByYear W21352423782019 @default.
- W2135242378 countsByYear W21352423782020 @default.
- W2135242378 countsByYear W21352423782021 @default.
- W2135242378 countsByYear W21352423782022 @default.
- W2135242378 countsByYear W21352423782023 @default.
- W2135242378 crossrefType "journal-article" @default.
- W2135242378 hasAuthorship W2135242378A5019261801 @default.
- W2135242378 hasAuthorship W2135242378A5023586883 @default.
- W2135242378 hasAuthorship W2135242378A5035948406 @default.
- W2135242378 hasBestOaLocation W21352423781 @default.
- W2135242378 hasConcept C126322002 @default.
- W2135242378 hasConcept C142724271 @default.
- W2135242378 hasConcept C155710745 @default.
- W2135242378 hasConcept C164705383 @default.
- W2135242378 hasConcept C168563851 @default.
- W2135242378 hasConcept C178853913 @default.
- W2135242378 hasConcept C204787440 @default.
- W2135242378 hasConcept C27081682 @default.
- W2135242378 hasConcept C2776645727 @default.
- W2135242378 hasConcept C2777335384 @default.
- W2135242378 hasConcept C2780074459 @default.
- W2135242378 hasConcept C2781185063 @default.
- W2135242378 hasConcept C42219234 @default.
- W2135242378 hasConcept C44249647 @default.
- W2135242378 hasConcept C71924100 @default.
- W2135242378 hasConcept C82789193 @default.